Category: MassDevice.com Earnings RoundupSyndicate content

Edwards Lifesciences posts double-digit Q3 sales, earnings increases

October 23, 2014 by Brad Perriello

Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.

Edwards Lifesciences posts double-digit Q3 sales, earnings increases

Boston Scientific, Bard CEOs cool on consolidation

October 23, 2014 by Brad Perriello

The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.

Boston Scientific, Bard CEOs cool on consolidation

Bard shares gain on nearly 50% earnings rise

October 23, 2014 by Brad Perriello

C.R. Bard reports a 3rd-quarter earnings gain of nearly 50% and raises its guidance for the rest of the year, sending share prices up this morning on Wall Street.

Bard shares gain on nearly 50% earnings rise

C.R. Bard (NYSE:BCR) shares are up more than 3% this morning on Wall Street after the medical device company reported that its 3rd-quarter earnings rose 47.0% compared with the same period last year.

Zimmer posts Q3 earnings above expectations, narrows guidance

October 23, 2014 by Brad Perriello

Zimmer Holdings says its 3rd-quarter earnings beat expectations and narrows its sales and earnings guidance for the rest of the year.

Zimmer posts Q3 earnings above expectations, narrows guidance

Zimmer's (NYSE:ZMH) 3rd-quarter earnings came in ahead of expectations on strong performances from its core knee and hip implant businesses.

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

October 22, 2014 by MassDevice

Abbott says it will go ahead with its plan to deal its generic pharmaceuticals line to Mylan for $5.3 billion and reports 3rd-quarter sales in line with expectations.

Abbott to go ahead with $5.3B Mylan deal, says 3rd-quarter sales match forecasts

Boston Scientific's Q3 profits rise on heart device sales

October 22, 2014 by MassDevice

Sales of its cardiac rhythm management devices help boost Boston Scientific above expectations for the 3rd quarter.

Boston Scientific's Q3 profits rise on heart device sales

Intuitive Surgical shows improvement despite profit decline

October 21, 2014 by MassDevice

Intuitive Surgical jumps in after-hours trading on better-than-expected 2nd-quarter sales and earnings, raised lower end of revenues outlook.

Intuitive Surgical shows improvement despite profit decline
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp